Fueled by federal funding, JHU researchers and scientists seek investors to back their ideas to bring discoveries to the market| The Hub
This novel approach could significantly reduce the need for invasive, often painful biopsies| The Hub
Hopkins cancer expert Liz Jaffee discusses what federal budget cuts might mean for patient care and future cures; NIH grant terminations affect some of the nation's most promising young scientists, including two Hopkins doctoral students| The Hub
Bernie was born with congenital glaucoma, a condition that requires urgent intervention. A team of pediatric ophthalmologists at Wilmer Eye Institute acted quickly to save her eyesight.| The Hub
Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist at Johns Hopkins. But those who live with autoimmune diseases could suffer the greatest consequences.| The Hub
The Johns Hopkins-led OUtMATCH study, which enrolled clinical trial participants at 10 locations across the U.S., leads to the second-ever FDA-approved food allergy treatment| The Hub
Cuts to NIH funding for biostatistical research would erode the United States' competitive edge, hindering the health, economy, and overall security of the nation| The Hub
Experts at Johns Hopkins and across the country work together to better understand the behavior and characteristics of respiratory viruses, how our immune system responds to them, and how we can prevent serious illness| The Hub
Detection of cancer before a clinical diagnosis could give patients and caregivers more time for intervention and may lead to better outcomes because tumors are more likely to be curable| The Hub
A genetic mutation and evolutionary trick fuels horses' exceptional athleticism, findings that may advance scientific understanding and treatments for inherited and age-related diseases in people| The Hub
Falls are the leading cause of injury-related death among seniors in the United States. Johns Hopkins researcher Kathleen Cullen studies the vestibular system in our inner ear, integral to maintaining balance.| The Hub
JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars Program, an initiative that has led to research and treatment breakthroughs for the genetic condition neurofibromatosis type 1| The Hub
Medicine| The Hub
The Center on Aging and Health, one of JHU's largest recipients of NIH funds, conducts critical work that provides real-time insights into the condition and care of older Americans| The Hub
Backed by NIH funding, Muyinatu 'Bisi' Bell's innovative work is enhancing diagnostic accuracy, improving surgical precision, and ensuring equitable health care for all patients| The Hub
Electrical engineer Mounya Elhilali relies on federal funding to push the boundaries of how technology can enhance human perception| The Hub
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins| The Hub